Jichuan Pharmaceutical: Mr. Cao Fei's tender offer to acquire company shares has been completed.

Jichuan Pharmaceutical Announcement: Mr. Cao Fei has issued a comprehensive offer to purchase all unlimited circulating shares of the listed company held by shareholders other than Mr. Cao Longxiang, Jiangsu Jichuan Holdings Group Co., Ltd., and Tibet Jichuan Enterprise Management Co., Ltd. The quantity of shares to be purchased in this offer is 351 million shares, accounting for 38.06% of the total share capital of the company, with an offer price of 24.85 yuan per share. The offer period is from June 18, 2025 to July 17, 2025. As of July 17, 2025, the total number of shareholders who have accepted the offer is 34, with a total of 16,300 shares, accounting for 0.0018% of the total share capital of the company. Mr. Cao Fei has fulfilled the relevant obligations as required, and the settlement and transfer procedures of this offer have been completed. Mr. Cao Fei directly holds 16,300 shares of the company, indirectly controls 417 million shares of the listed company through Jichuan Holdings controlled by him, and indirectly controls 100 million shares of the listed company through Tibet Jichuan controlled by him. Mr. Cao Fei directly and indirectly controls 5.17 billion shares of the company, accounting for 56.07% of the total share capital. Mr. Cao Fei and his concerted action person Mr. Cao Longxiang jointly control 5.64 billion shares of the company, accounting for 61.15% of the total share capital.